Abstract
Around 70% of men presenting with prostate cancer will have organ-confined disease, with the majority presenting with low- or intermediate-risk prostate cancer. This article reviews the evidence supporting the current standard of care in radiation oncology for the evaluation and management of men with intermediate-risk prostate cancer. Dose escalation, hormonal therapy, combined modality therapy, and modern techniques for the delivery of radiation therapy are reviewed.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 113-124 |
| Number of pages | 12 |
| Journal | Therapeutic Advances in Urology |
| Volume | 4 |
| Issue number | 3 |
| DOIs | |
| State | Published - Jun 2012 |
Fingerprint
Keywords
- androgen deprivation
- brachytherapy
- dose escalation
- external beam
- intermediate risk
- outcomes
- prostate cancer
- radiation
- review
ASJC Scopus subject areas
- Urology
Cite this
Radiation treatment for patients with intermediate-risk prostate cancer. / Greene, David E.; Mayadev, Jyoti S.; Valicenti, Richard K.
In: Therapeutic Advances in Urology, Vol. 4, No. 3, 06.2012, p. 113-124.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Radiation treatment for patients with intermediate-risk prostate cancer
AU - Greene, David E.
AU - Mayadev, Jyoti S.
AU - Valicenti, Richard K
PY - 2012/6
Y1 - 2012/6
N2 - Around 70% of men presenting with prostate cancer will have organ-confined disease, with the majority presenting with low- or intermediate-risk prostate cancer. This article reviews the evidence supporting the current standard of care in radiation oncology for the evaluation and management of men with intermediate-risk prostate cancer. Dose escalation, hormonal therapy, combined modality therapy, and modern techniques for the delivery of radiation therapy are reviewed.
AB - Around 70% of men presenting with prostate cancer will have organ-confined disease, with the majority presenting with low- or intermediate-risk prostate cancer. This article reviews the evidence supporting the current standard of care in radiation oncology for the evaluation and management of men with intermediate-risk prostate cancer. Dose escalation, hormonal therapy, combined modality therapy, and modern techniques for the delivery of radiation therapy are reviewed.
KW - androgen deprivation
KW - brachytherapy
KW - dose escalation
KW - external beam
KW - intermediate risk
KW - outcomes
KW - prostate cancer
KW - radiation
KW - review
UR - http://www.scopus.com/inward/record.url?scp=84861864345&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84861864345&partnerID=8YFLogxK
U2 - 10.1177/1756287212442977
DO - 10.1177/1756287212442977
M3 - Article
C2 - 22654963
AN - SCOPUS:84861864345
VL - 4
SP - 113
EP - 124
JO - Therapeutic Advances in Urology
JF - Therapeutic Advances in Urology
SN - 1756-2872
IS - 3
ER -